Summary of patient characteristics at enrollment
| Outcome group . | Median no. of months from ITP diagnosis to enrollment (range) . | Median age at enrollment, y (range) . | Gender (F, M) . | Steroids* . | IVIG* . | Danazol* . |
|---|---|---|---|---|---|---|
| Off treatment (n = 12) | 4 (1-11) | 29.5 (21-63) | 8, 4 | 10 | 9 | 2 |
| On treatment (n = 7) | 2 (1-11) | 29 (18-56) | 6, 1 | 7 | 4 | 1 |
| Splenectomy (n = 8) | 2 (2-10) | 25 (20-61) | 7, 1 | 8 | 3 | 1 |
| Outcome group . | Median no. of months from ITP diagnosis to enrollment (range) . | Median age at enrollment, y (range) . | Gender (F, M) . | Steroids* . | IVIG* . | Danazol* . |
|---|---|---|---|---|---|---|
| Off treatment (n = 12) | 4 (1-11) | 29.5 (21-63) | 8, 4 | 10 | 9 | 2 |
| On treatment (n = 7) | 2 (1-11) | 29 (18-56) | 6, 1 | 7 | 4 | 1 |
| Splenectomy (n = 8) | 2 (2-10) | 25 (20-61) | 7, 1 | 8 | 3 | 1 |
Number of patients in each outcome group receiving these treatments prior to enrollment.